A detailed history of Gw&K Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 320,781 shares of ABBV stock, worth $56.2 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
320,781
Previous 325,845 1.55%
Holding current value
$56.2 Million
Previous $55.9 Million 13.35%
% of portfolio
0.54%
Previous 0.51%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.84 - $199.33 $829,685 - $1.01 Million
-5,064 Reduced 1.55%
320,781 $63.3 Million
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $1.09 Million - $1.27 Million
-7,013 Reduced 2.11%
325,845 $55.9 Million
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $587,817 - $669,763
-3,678 Reduced 1.09%
332,858 $60.6 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $1.27 Million - $1.43 Million
-9,204 Reduced 2.66%
336,536 $52.2 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $1.05 Million - $1.21 Million
-7,838 Reduced 2.22%
345,740 $51.5 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $5.81 Million - $7.23 Million
-43,834 Reduced 11.03%
353,578 $47.6 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $630,354 - $725,947
4,359 Added 1.11%
397,412 $63.3 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $400,960 - $480,857
-2,899 Reduced 0.73%
393,053 $63.5 Million
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $615,352 - $705,769
-4,585 Reduced 1.14%
395,952 $53.1 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $2.73 Million - $3.47 Million
-19,836 Reduced 4.72%
400,537 $61.3 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $5.88 Million - $7.29 Million
-44,524 Reduced 9.58%
420,373 $68.1 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $297,795 - $376,797
-2,772 Reduced 0.59%
464,897 $62.9 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $223,014 - $253,154
2,096 Added 0.45%
467,669 $50.4 Million
Q2 2021

Aug 10, 2021

SELL
$105.21 - $117.21 $83,010 - $92,478
-789 Reduced 0.17%
465,573 $52.4 Million
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $588,327 - $647,677
-5,751 Reduced 1.22%
466,362 $50.5 Million
Q4 2020

Feb 05, 2021

SELL
$80.49 - $108.67 $266,180 - $359,371
-3,307 Reduced 0.7%
472,113 $50.6 Million
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $489,257 - $574,226
-5,695 Reduced 1.18%
475,420 $41.6 Million
Q2 2020

Aug 06, 2020

SELL
$73.37 - $98.18 $460,103 - $615,686
-6,271 Reduced 1.29%
481,115 $47.2 Million
Q1 2020

May 11, 2020

SELL
$64.5 - $97.79 $554,184 - $840,211
-8,592 Reduced 1.73%
487,386 $37.1 Million
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $316,001 - $395,385
-4,381 Reduced 0.88%
495,978 $43.9 Million
Q3 2019

Nov 05, 2019

BUY
$62.98 - $75.72 $4.55 Million - $5.47 Million
72,240 Added 16.87%
500,359 $37.9 Million
Q2 2019

Aug 06, 2019

SELL
$65.7 - $83.98 $527,373 - $674,107
-8,027 Reduced 1.84%
428,119 $31.1 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $146,566 - $172,501
-1,900 Reduced 0.43%
436,146 $35.1 Million
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $1.03 Million - $1.27 Million
-13,265 Reduced 2.94%
438,046 $40.4 Million
Q3 2018

Nov 06, 2018

SELL
$88.91 - $98.84 $806,413 - $896,478
-9,070 Reduced 1.97%
451,311 $42.7 Million
Q2 2018

Aug 07, 2018

SELL
$89.78 - $106.23 $1.3 Million - $1.54 Million
-14,476 Reduced 3.05%
460,381 $42.7 Million
Q1 2018

May 08, 2018

SELL
$92.01 - $123.21 $8.47 Million - $11.3 Million
-92,097 Reduced 16.24%
474,857 $44.9 Million
Q4 2017

Jan 19, 2018

SELL
$89.56 - $98.21 $825,116 - $904,808
-9,213 Reduced 1.6%
566,954 $54.8 Million
Q3 2017

Oct 11, 2017

BUY
$69.85 - $89.22 $40.2 Million - $51.4 Million
576,167
576,167 $51.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.